ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668494 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668494; 2) Community: the network communities that were significantly associated with the response to NSC 668494; 3) Molecule: the relationships between components within communities and NSC 668494; 4) MDR: the compounds that were significantly associated with the NSC 668494.

NSC Compound Enrichment Correlation
NSC 762555 Null 0.0252562667234373 -0.07673648
NSC 8120 Claviform 0.0252562667234373 0.2607934
NSC 128635 Null 0.0268790882218881 0.27533034
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0268790882218881 0.17567753
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0268790882218881 0.40892324
NSC 135073 WITHACNISTIN 0.0268790882218881 0.2277025
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0268790882218881 0.25453623
NSC 252628 1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)seleno]- 0.0268790882218881 0.058907837
NSC 287069 Epicorazine A 0.0268790882218881 0.38726934
NSC 361605 Uracil, 5-fluoro-1-[tetrahydro-5-oxo-3-(trimethylsiloxy)-2-furanyl]-, (2S,trans)- 0.0268790882218881 0.32028124
Total:100  Current:60    [First] [Prev] [Next] [Last]